Aeilko H Zwinderman Selected Research

olpadronic acid

11/2003	Determinants of induction and duration of remission of Paget's disease of bone after bisphosphonate (olpadronate) therapy.
4/2002	Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aeilko H Zwinderman Research Topics

Disease

28	Coronary Artery Disease (Coronary Atherosclerosis) 09/2020 - 05/2002
16	Marfan Syndrome (Marfan's Syndrome) 12/2021 - 01/2010
16	Asthma (Bronchial Asthma) 01/2019 - 08/2002
14	Heart Failure 01/2022 - 08/2014
14	Neoplasms (Cancer) 06/2021 - 11/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2002
12	Atherosclerosis 01/2019 - 01/2002
11	Inflammation (Inflammations) 01/2017 - 08/2002
11	Delirium 12/2011 - 10/2007
10	Sepsis (Septicemia) 01/2021 - 11/2015
10	Infections 01/2021 - 02/2006
10	Rheumatoid Arthritis 01/2019 - 01/2002
9	Coronary Disease (Coronary Heart Disease) 01/2021 - 03/2004
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 04/2007
6	Pneumonia (Pneumonitis) 01/2021 - 10/2011
6	Cognitive Dysfunction 07/2012 - 10/2007
6	Myocardial Infarction 03/2012 - 12/2002
6	Pathologic Constriction (Stenosis) 12/2005 - 01/2002
5	Type 2 Diabetes Mellitus (MODY) 09/2021 - 03/2008
5	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2017 - 10/2011
5	Stroke (Strokes) 04/2015 - 03/2009
5	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 03/2015 - 08/2003
5	Premature Ejaculation 02/2014 - 10/2004
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 07/2015
4	Shock 01/2022 - 11/2015
4	Atrial Fibrillation 01/2021 - 06/2013
4	Critical Illness (Critically Ill) 01/2021 - 03/2017
4	Congenital Heart Defects (Congenital Heart Defect) 01/2021 - 04/2016
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 05/2002
4	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2002
4	Arthritis (Polyarthritis) 01/2019 - 10/2002
4	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 04/2002
4	Hypertension (High Blood Pressure) 10/2017 - 02/2007
3	Mood Disorders (Mood Disorder) 01/2021 - 10/2020
3	Pneumococcal Infections 01/2021 - 10/2011
3	Aortic Dissection 11/2020 - 04/2012
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 04/2005
3	Tetralogy of Fallot (Fallot Tetralogy) 01/2018 - 04/2007
3	Aortic Diseases 11/2017 - 01/2012
3	Eosinophilia 03/2015 - 09/2004
3	Ventricular Tachycardia 08/2014 - 04/2007
3	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2007 - 02/2003
2	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2016

Drug/Important Bio-Agent (IBA)

24	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2003
12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 06/2003
10	HDL CholesterolIBA 01/2018 - 05/2002
8	LipidsIBA 01/2019 - 04/2004
7	CholesterolIBA 03/2009 - 01/2002
6	Losartan (Cozaar)FDA LinkGeneric 11/2020 - 01/2010
6	CytokinesIBA 01/2019 - 09/2008
6	Angiotensin Receptor AntagonistsIBA 01/2018 - 04/2012
6	Pravastatin (Pravachol)FDA LinkGeneric 03/2011 - 05/2003
5	Proteins (Proteins, Gene)FDA Link 09/2021 - 11/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2019 - 09/2008
5	oxidized low density lipoproteinIBA 01/2019 - 11/2005
5	Cholesterol Ester Transfer ProteinsIBA 09/2008 - 01/2003
4	Fibrillin-1IBA 12/2021 - 12/2011
4	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 06/2011
4	SteroidsIBA 01/2019 - 08/2002
4	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2011
4	Diphosphonates (Bisphosphonates)IBA 11/2017 - 04/2002
4	Complement System Proteins (Complement)IBA 01/2017 - 10/2011
4	LDL CholesterolIBA 11/2016 - 03/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2014 - 09/2004
4	Apolipoproteins E (ApoE)IBA 10/2009 - 04/2005
4	ApolipoproteinsIBA 10/2009 - 06/2006
3	Gemcitabine FDA Link 10/2022 - 07/2015
3	Immunoglobulin E (IgE)IBA 01/2021 - 01/2019
3	Advanced Glycation End ProductsIBA 01/2021 - 10/2020
3	phospholambanIBA 01/2021 - 08/2014
3	AllergensIBA 01/2021 - 08/2002
3	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 10/2017
3	Syntex adjuvant formulationIBA 01/2021 - 10/2020
3	Biological ProductsIBA 01/2020 - 01/2013
3	Monoclonal AntibodiesIBA 01/2019 - 10/2011
3	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2007
3	C-Reactive ProteinIBA 01/2019 - 04/2008
3	Insulin (Novolin)FDA Link 01/2018 - 09/2011
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 08/2017 - 10/2004
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2017 - 03/2011
3	Pharmaceutical PreparationsIBA 07/2015 - 07/2007
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2014 - 01/2010
3	Interleukin-8 (Interleukin 8)IBA 08/2011 - 09/2008
3	EnzymesIBA 03/2009 - 06/2005
3	Atorvastatin (Lipitor)FDA Link 09/2008 - 11/2005
3	Simvastatin (Zocor)FDA LinkGeneric 04/2008 - 08/2003
3	ametantrone (HAQ)IBA 09/2003 - 10/2002

Therapy/Procedure

36	Therapeutics 01/2021 - 05/2002
8	Percutaneous Coronary Intervention 08/2013 - 04/2005
7	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2021 - 04/2007
4	Chemoradiotherapy 10/2022 - 03/2016
4	Radiotherapy 01/2020 - 11/2009
4	Stents 09/2010 - 01/2003
3	Electronic Nose 05/2015 - 12/2009
3	Length of Stay 04/2015 - 07/2012
3	Secondary Prevention 10/2011 - 05/2009
3	Resistance Training 06/2005 - 01/2002
2	Immunotherapy 01/2022 - 03/2015
2	Cardiopulmonary Resuscitation (CPR) 01/2022 - 08/2015